Cellares is developing better manufacturing practices for cell therapies. Cell therapies have great potential to treat diseases with over 600 clinical trials underway, but they face a serious problem - the ability to scale production. To solve this, Cellares has created the Cell Shuttle, a ‘factory-in-a-box’ for industrial-scale cell therapy manufacturing. The cost-effective, automated Cell Shuttle enables the parallel production of thousands of cell therapy doses per month. The Shuttle is a closed system enabling a 70% cost reduction and a 3-fold reduction in failure rates. Customers can design and monitor their cell therapy production with the Cellares Software Platform, which in turn helps Celares develop better products and meet patient demand.